Cargando…

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis

BACKGROUND: Both National Comprehensive Cancer Network and Chinese guidelines recommend beginning prostate-specific antigen (PSA) screening for men aged 50 years or 45 years with a family history because they were at a higher risk of developing prostate cancer. Several model-based economic evaluatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Xiaojian, Ye, Dingwei, Gu, Chengyuan, Huang, Yongqiang, Gu, Weijie, Dai, Bo, Zhang, Hailiang, Zhu, Yao, Yang, Han, Qu, Shuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646126/ https://www.ncbi.nlm.nih.gov/pubmed/34917218 http://dx.doi.org/10.1016/j.curtheres.2021.100653

Ejemplares similares

PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population
por: Cao, Dalong, et al.
Publicado: (2018)

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic
por: Zhu, Yu, et al.
Publicado: (2022)

Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis
por: Qu, Yuanyuan, et al.
Publicado: (2015)

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer
por: Gu, Chengyuan, et al.
Publicado: (2015)

China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis
por: Zhang, Zhiguo, et al.
Publicado: (2021)

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity
por: Wei, Yu, et al.
Publicado: (2023)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
por: Bian, Xiaojie, et al.
Publicado: (2015)

Prostate hyperplasia in St Mary's Hospital Lacor: utility of prostate specific antigen in screening for prostate malignancy
por: Okidi, Ronald, et al.
Publicado: (2020)

Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men
por: Zhang, Guiming, et al.
Publicado: (2015)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
por: Qu, Yuanyuan, et al.
Publicado: (2015)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations
por: Wang, Mengyun, et al.
Publicado: (2016)

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
por: Ma, Jian, et al.
Publicado: (2018)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
por: Wan, Fangning, et al.
Publicado: (2014)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
por: Gu, Weijie, et al.
Publicado: (2015)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature
por: Chang, Kun, et al.
Publicado: (2013)

Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
por: de Abreu, Darci Schiavon
Publicado: (2011)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
por: Cabarkapa, Sonja, et al.
Publicado: (2016)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
por: Narain, Tushar Aditya, et al.
Publicado: (2022)

Complicated variation of simple renal cyst usually means malignancy: results from a cohort study
por: Qin, XiaoJian, et al.
Publicado: (2014)

Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial
por: Qin, Xiaojian, et al.
Publicado: (2022)

Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis
por: Yan, Jianzhou, et al.
Publicado: (2022)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Screening for prostate cancer: a study on the free and total prostate specific antigen
por: Mediu, Ridvana, et al.
Publicado: (2021)

Prostate-specific antigen screening for prostate cancer: An old but never-ending story
por: Kim, Sun Il
Publicado: (2023)

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series
por: Gu, Weijie, et al.
Publicado: (2015)

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?
por: Zhang, Guiming, et al.
Publicado: (2014)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
por: Hu, Xin, et al.
Publicado: (2019)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f3q45hatu75gfls8ibdq7icg2v